Oral complement factor D inhibitors
US-12558341-B2 · Feb 24, 2026 · US
This page is not indexed by search engines while we improve data quality.
Spaulding Andrew E patents
Spaulding Andrew E is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Spaulding Andrew E |
| Total patents | 4 |
| First publication | Aug 15, 2024 |
| Latest publication | Feb 24, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Oral complement factor d inhibitors
US-2025275991-A1 · Sep 4, 2025 · US
Oral complement factor d inhibitors
US-2025186391-A1 · Jun 12, 2025 · US
Imidazole-containing inhibitors of alk2 kinase
US-2024270750-A1 · Aug 15, 2024 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Biocryst Pharm Inc | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D495/04 | 3 |
| C07D491/048 | 3 |
| C07D471/04 | 3 |
| C07D405/04 | 3 |
| C07D307/81 | 3 |